Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/ritonavir QD vs BID in HIV
NCT00043966Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Jul 2002; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00043966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043966.